Catalyst
Slingshot members are tracking this event:
Gilead (GILD) Expects to Release Futility Analysis in Q3 2017 From Phase 3 Trial Evaluating GS-5745 in Gastric Cancer
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| GILD |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
May 30, 2017
Occurred Source:
http://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.TPS4139
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Futility Analysis, Phase 3, Gs-5745, Gastric Cancer
